Human equilibrative nucleoside transporter 1 are predictive biomarkers for Gemcitabine-based chemoradiotherapy in resected pancreatic cancer patients: a retrospective cohort study

Background and Aim Pancreatic cancer is reported to be one of the cancer-related deaths all over the world. Gemcitabine has been identified as one of the important therapies of malignant diseases. Gemcitabine cellular uptake is allowed by the transporter protein, human equilibrative nucleoside trans...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Al-Azhar Assiut medical Journal : AAMJ 2023-01, Vol.21 (1), p.35
Hauptverfasser:	Elsherif, Abdelhalim A, Kodama, Yuzo, Uza, Norimitsu, Hussein, Mohammed S, Elhawary, Mostafa
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological markers Cancer Care and treatment Carrier proteins Chemotherapy Dosage and administration Gemcitabine Health aspects Medical research Medicine, Experimental Pancreatic cancer Patient outcomes Physiological aspects Protein kinases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!